Back to results
US 2014/0234270 A1Published application
Treatment wth alphat selective ligands
AssigneeTargacept, Inc.
InventorsMerouane Bencherif, Kristen Jordan, Terry Hauser, Steven M. Toler, Sharon Rae Letchworth, David C. Kombo
Life of this patent
Estimating the term…
Abstract
The present invention includes methods, uses, and selective alpha7 nAChR ligands for treating or preventing disease and disorders in which stimulation of neurogenesis is ameliorative; namely, wherein the recruitment of neurogenesis is therapeutic.
Claims1
A method for stem cell therapy comprising:
- administering a selective α7 agonist, wherein said administration further comprises:
- implanting stem cells or reactivating endogenous stem cells in a host in need of treatment
- protecting said stem cells against host pathology;
- stimulating migration and neuronal differentiation;
- and
- promoting selective maturation to functional neurons.
3 more elements
Dependencies are inferred from the claim text.